Hyderabad: The envoys of 64 countries visited Biological E Limited and Bharat Biotech limited, the two premier industrial units in the forefront of vaccine manufacturing in the city on December 9.

An official release from Telangana government said that the visit is organised by the Ministry of External Affairs to familiarize the foreign ambassadors and high commissioners about some key research and development activities being taken up by the country.

The high-level contingent was divided into two batches, the first batch was taken to Bharat Biotech Ltd., while the second batch went around Biological E Limited and visited the facilities there. Later the second batch which earlier visited Bharat biotech Ltd. was taken around Biological E limited. Similarly, the team which visited Biological E limited was later taken to Bharat Biotech.

"Telangana state though being the youngest state in the country has achieved tremendous progress during the last six years. The state has been a front ranker in the ease of doing business in the country, The state is home to some of the top valued companies such as Google, Apple, Facebook, Amazon, Microsoft Most of these companies have their largest establishments outside the US in Hyderabad," said Somesh Kumar, Chief Secretary, Telangana.

He also informed that the combined value of the pharma sector in the state is around 50 billion US dollars. Hyderabad is the vaccine hub of not only India but the entire world with 33 per cent of the entire vaccine production being done in Hyderabad.

The Chief Secretary also briefed the diplomats that the state has formulated a new TSIPASS policy for speedy approvals to the industries. Industries who do not get permission within fifteen days are deemed to have been approved. This policy has proved to be a game-changer and during the last six years, around 14 thousand units have been grounded in the state.

Newsmeter Network

An independent digital media platform that brings you credible news stories and Analysis of current affairs as they unfold.

Next Story